let-7 and miR-17-92: small-sized major players in lung cancer development

Hirotaka Osada1, Takashi Takahashi

  • 1Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.

Cancer Science
|August 26, 2010
PubMed

Insights

MicroRNA (miRNA) alterations are implicated in lung cancer development. This review details how specific miRNA changes contribute to lung cancer pathogenesis, offering insights for future diagnostics and treatments.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • miRNA alterations are linked to human cancers, particularly lung cancer.
  • Specific miRNA dysregulations, like let-7 family downregulation and miR-17-92 cluster overexpression, are common in lung cancer.

Purpose of the Study:

  • To review recent advances in understanding miRNA molecular functions.
  • To elucidate the role of miRNA alterations in lung cancer pathogenesis.
  • To highlight the potential of miRNAs in cancer diagnosis and treatment.

Main Methods:

  • Literature review of recent studies on miRNA functions in lung cancer.
  • Analysis of molecular mechanisms underlying miRNA involvement in tumorigenesis.
  • Synthesis of current knowledge on miRNA alterations in lung cancer.

Main Results:

  • miRNA alterations significantly impact biological processes and gene expression.
  • Downregulation of tumor-suppressive let-7 miRNAs and overexpression of oncogenic miR-17-92 are frequent in lung cancer.
  • Molecular insights into miRNA roles in lung cancer development are rapidly accumulating.

Conclusions:

  • miRNA alterations are crucial in lung cancer pathogenesis.
  • Further research on miRNA mechanisms will enhance understanding of lung cancer development.
  • miRNAs hold promise for novel strategies in lung cancer diagnosis and therapy.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...